fezakinumab human monoclonal antibody designed treatment psoriasis rheumatoid wyeth discovered initially developed drug clinical development continued company acquired pfizer fezakinumab combination methotrexate completed phase ii trial rheumatoid data released small phase ii trial fezakinumab showed significant improvement scoring atopic dermatitis scorad score patients severe atopic immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikifezakinumab